Bank Of America Corp Ardelyx, Inc. Put Options Transaction History

Bank Of America Corp

3 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2024 Aug 14, 2024	SELL	$5.89 - $9.31 $47,120 - $74,480	-8,000 Reduced 3.57%	216,000 $1.6 Million
Q1 2024 May 15, 2024	SELL	$6.05 - $9.74 $207,515 - $334,082	-34,300 Reduced 13.28%	224,000 $1.64 Million
Q2 2023 Aug 14, 2023	BUY	$3.23 - $4.95 $834,309 - $1.28 Million	258,300 New	258,300 $875,000

210

144M

1.01M

1.43M

Ticker ARDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 154,636,000
Market Cap $895M
Description
Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

Stay updated on Bank Of America Corp with notifications on news.